Abstract:Background Cyclooxygenase-2 (COX-2) is a key factor in the development of colorectal cancer, and non-steroidal anti-inflammatory drugs (NSAIDs) have anti-colorectal cancer activity. However, the potential molecular mechanism of the COX-2 selective inhibitor effect on proliferation and apoptosis of colon cancer cells is unclear. In this study, we have demonstrated for the first time that the Delta1/Notch1 signal transduction pathway mediates the COX-2 selective inhibitor effect on colorectal cancer cells, and we reveal the mechanism of the Notch1 pathway in terms of regulating the proliferation and apoptosis of colorectal cancer cells. Methods and Result Colon cancer cell lines HT-29 and SW480 were treated with NS-398 (a COX-2 selective inhibitor) and DAPT (a gamma-secretase inhibitor). The colormetric MTT cell proliferation assay and flow cytometry were used to measure cell proliferation and apoptosis. Reverse transcriptase (RT)-PCR and ELISA analyses were used to detect the levels of COX-2 mRNA expression and prostaglandin E2 (PGE2) concentration from the two cell lines, respectively. The expression of the Notch1, Delta1, ICN, Hes1 and NF-κB2 proteins was measured by Western blot. Immunohistochemistry results showed that Notch1 was expressed mainly in the cytoplasm and ICN mainly in the nucleus. COX-2 mRNA was highly expressed in HT-29 cells but not in SW480 cells. Both COX-2 mRNA expression and PGE2 concentration decreased in HT-29 cells treated with NS-398; however, PGE2 levels did not change in SW480 cells treated with NS-398. NS-398 and DAPT inhibited cell proliferation and induced apoptosis in a dose time-dependent manner accompanied by significantly decreased Notch1 activity ( P < 0.01), and resulted in a significant down-regulation of Hes1 and NF-κB2 ( P < 0.01). Conclusions Our results show that the selective COX-2 inhibitor may inhibit the proliferation and induce apoptosis in colon cancer cells through the COX-2-dependent pathway (HT-29) by decreasing the COX-2 mRNA/PGE2 levels and the activity of the COX-2-independent pathway (SW480). The Notch1 signal pathway mediates the effects of the COX-2 inhibitor on the proliferation and apoptosis of colon cancer cells. This may be a new target of the selective COX-2 inhibitor effect on colon cancer.

Cyclooxygenase-2-independent Mechanism Study of Selective Cyclooxygenase-2 Inhibitor on Proliferation and Apoptosis of Colon Caner Cells

The Study of Selective Cyclooxygenase-2 Inhibitor NS-398 on Proliferation and Apoptosis of Human Colon Cancer Cells

[Molecular Mechanism of Cyclooxygenase-2 Inhibitor in Inhibition of Proliferation of Colon Cancer Cells by Modulating Stat5 Signal Transduction Pathway].

The COX-2 Selective Inhibitor-Independent COX-2 Effect on Colon Carcinoma Cells is Associated with the Delta1/Notch1 Pathway

[Effects of Selective Cyclooxygenase-2 Inhibitor NS-398 on 5-Fluorouracil Chemotherapy and Progression of Colon Cells: an Experimental Study].

Effects of NS398, an inhibitor of cyclooxygenase 2, on the growth and apoptosis of human squamous cell carcinoma cell line Tca8113

Study on effect of cox-2 inhibitor on proliferation and invasion of human gastric cancer cells

STUDY ON THE EXPRESSION OF CYCLOOXYGENASE-2 IN HEPATOCELLULAR CARCINOMA CELL LINES AND ON THE GROWTH INHIBITION EFFECT OF NS-398

Specific COX-2 Inhibitor NS398 Induces Apoptosis in Human Liver Cancer Cell Line HepG2 Through BCL-2

Flurbiprofen Suppresses the Inflammation, Proliferation, Invasion and Migration of Colorectal Cancer Cells Via COX2.

In Vitro Enhancement of Radiation-Induced Apoptosis in Human Hepatoma Cell Line HepG2 by a Selective Inhibitor of Cyclooxygenase-2 Enzyme NS -398

Inhibitory Effect of Platycodin D on Human Colonic Cancer SW620 Cell Proliferation

[Study of COX-2 Expression and Angiogenesis in Non-Small Cell Lung Cancer].

Apoptosis Induced by Celecoxib Eombinated with Cisplatin in Human Osteosarcoma Cell Line MG-63 Via Down-Regulation of PI3K/Akt

NS398 Induces Apoptosis of COX-2 Negatively Expressed Human Prostate Cancer Cell Line PC-3 in Vitro

[NS398 Induced Apoptosis in Pancreatic Carcinoma Cell Strain BxPC-3 Through a COX-2-in Dependent Pathway].

Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells

The mechanism of inhibition of NS-398 on malignant biological characteristics of ovarian cancer

Cyclooxygenase-2 Inhibitor Ns398 Enhances Radiosensitivity of Radioresistant Esophageal Cancer Cells by Inhibiting Akt Activation and Inducing Apoptosis

The Cyclooxygenase-2 Inhibitor NS-398 Inhibits Proliferation and Induces Apoptosis in Human Osteosarcoma Cells Via Downregulation of the Survivin Pathway.

Molecular Mechanism for COX-2 in Carcinogenesis